XANAX UPJOHN BAR 2.0mg (Pfizer) 🇺🇸

Xanax 2mg (Upjosh55)(Pfizer) 🇺🇸

(Alphazolam 2mg)

Product Name and Active Ingredient

Brand Name: XANAX® UPJOHN BAR 2.0 mg

Generic Name: Alprazolam

Drug Class: Benzodiazepine (Anxiolytic)

Composition

Active Ingredient: Alprazolam 2 mg

Manufacturing and Manufacturer

Manufactured in: United States

Manufacturer: Upjohn Company (now part of Pfizer Inc.)

50 Tablets per 1 Jar

#Alprazolam, #XANAX, #XANZ, #XANAXBAR, #XANNY, #XANZBAR, #XANNYBAR, #MTN, #MTN1.0, #MTN0.5, #Trankimazin, #Mersi, #Xans, #xans , #XANS,

#Benzodiazepines , #Benzodiazepine, #benzo , #benzos , #Benzo , #Benzos , #BENZO, #BENZOS

Indications

**Treatment of Anxiety Disorders

**Treatment of Panic Disorder

**Anxiety associated with Depression

Warnings and Precautions

Use in the Elderly:

**Use with caution due to increased risk of falls and other side effects.

Concomitant Use with Alcohol or CNS Depressants:

**May enhance sedative effects and risk of respiratory depression.

Use in Pregnancy and Lactation:

**Not recommended due to potential risks to the fetus and nursing infant.

Abrupt Discontinuation:

**May lead to withdrawal symptoms such as seizures, anxiety, or depression.

History and Background

Development and Registration: Alprazolam was developed by Upjohn Laboratories in the late 1960s and patented in 1969.

Approval:Approved by the FDA in the United States in 1981.

Misuse and Abuse

Overdose or Combination with Other Substances:

**Can lead to addiction, withdrawal symptoms, or severe side effects such as respiratory depression.

Non-prescribed Use:

**Dangerous and illegal.

Additional Information

Consideration in Patients with Depression or Suicidal Thoughts:

**Use with caution as it may increase the risk of such behaviors.

Monitoring Treatment:

**Regular follow-up and dosage adjustments by healthcare professionals are essential.

There are no reviews yet.